NCT05714124Recruiting
Liver Embolization Approaches for Tumor Management
Liver Embolization Approaches for Tumor Management - Retrospective and Prospective Analysis of the Short-, Medium-, and Long-term Clinical Course of Patients Subjected to Embolization Treatment for Primary and Secondary Liver Neoplasms
Source: ClinicalTrials.gov · Last updated 12 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 580 (estimated)
- First submitted
- 25 Jan 2023
- Start date
- 21 May 2021
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- IRCCS San Raffaele
- Diseases
- Pancreatic cancer, Colorectal cancer, Liver and biliary tract cancer, Gastric and esophageal cancer
- NCT number
- NCT05714124
What you commit to
- Study type: Observational
- Planned participants: 580
- From 21 May 2021 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- diffuse extrahepatic disease
Other
- pregnant women
- patients with uncorrectable coagulopathy
- for lobar TACE and TARE - presence of bilodigestive shunt
- for TARE - \>20% hepatopulmonary shunt
Who the study is looking for
- ≥ 18 yoa
- patients with patients with primary or secondary liver disease not amenable for surgery or ablation
- patients with primary or secondary liver tumors candidates for major surgery prior to induction of hypertrophy
- able and willing to sign informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Ospedale San Raffaele Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.